FOXO (FOXO Technologies) ROA %: -12.85% (As of Mar. 2026)


What is FOXO Technologies ROA %?

FOXO Technologies FOXO -50.00% ROA % is -12.85% as of Mar. 2026. The stock has 5 warning signs investors should review. Among 686 Healthcare Providers & Services companies, FOXO Technologies ranks worse than 84.69% on this metric.

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. FOXO Technologies's annualized Net Income for the quarter that ended in Mar. 2026 was $-5.81 Mil. FOXO Technologies's average Total Assets over the quarter that ended in Mar. 2026 was $45.18 Mil. Therefore, FOXO Technologies's annualized ROA % for the quarter that ended in Mar. 2026 was -12.85%.

The historical rank and industry rank for FOXO Technologies's ROA % or its related term are showing as below:

FOXO' s ROA % Range Over the Past 10 Years
Min: -289.92   Med: -119.12   Max: -28.3
Current: -28.3

During the past 6 years, FOXO Technologies's highest ROA % was -28.30%. The lowest was -289.92%. And the median was -119.12%.

FOXO's ROA % is ranked worse than
84.69% of 686 companies
in the Healthcare Providers & Services industry
Industry Median: 1.75 vs FOXO: -28.30

FOXO Technologies  (OTCPK:FOXO) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Mar. 2026 )
=Net Income/Total Assets
=-5.808/45.182
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-5.808 / 20.672)*(20.672 / 45.182)
=Net Margin %*Asset Turnover
=-28.1 %*0.4575
=-12.85 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


FOXO Technologies ROA % Related Terms


FOXO Technologies ROA % Historical Data

* Premium members only.

The historical data trend for FOXO Technologies's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FOXO Technologies ROA % Chart

FOXO Technologies Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROA %
Get a 7-Day Free Trial -193.76 -289.92 -146.41 -58.47 -28.81

FOXO Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.90 -4.54 -14.70 -77.92 -12.85

FOXO vs WORX, MSPR, ESSID: ROA % Comparison

For the Health Information Services subindustry, FOXO Technologies's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FOXO Technologies ROA % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, FOXO Technologies's ROA % distribution charts can be found below:

* The bar in red indicates where FOXO Technologies's ROA % falls into.



FOXO Technologies ROA % Calculation

FOXO Technologies's annualized ROA % for the fiscal year that ended in Dec. 2025 is calculated as:

ROA %=Net Income (A: Dec. 2025 )/( (Total Assets (A: Dec. 2024 )+Total Assets (A: Dec. 2025 ))/ count )
=-12.43/( (41.708+44.578)/ 2 )
=-12.43/43.143
=-28.81 %

FOXO Technologies's annualized ROA % for the quarter that ended in Mar. 2026 is calculated as:

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-5.808/( (44.578+45.786)/ 2 )
=-5.808/45.182
=-12.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2026) net income data. ROA % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROA % →
What does a ROA % of -12.85% mean?
FOXO Technologies (FOXO) has a ROA % of -12.85% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on FOXO Technologies and its competitors. According to the industry distribution chart, FOXO Technologies ranks #581 out of 686 companies in the Healthcare Providers & Services industry, placing it in the top 84.7%.
Is FOXO Technologies' ROA % too high?
FOXO Technologies' current ROA % is -12.85%. Based on the distribution chart, FOXO Technologies ranks #581 out of 686 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does FOXO Technologies' ROA % compare to WORX and MSPR?
According to the Healthcare Providers & Services industry distribution chart, FOXO Technologies ranks #581 out of 686 companies for ROA %. This places FOXO Technologies in the lower half of its industry. The industry median ROA % is 1.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.75, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on FOXO Technologies and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. FOXO Technologies's current ROA % is -12.85%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FOXO Technologies stock overvalued right now?
Based on GuruFocus' analysis, FOXO Technologies (FOXO) is currently considered Possible Value Trap. The stock's GF Value™ is $5.87, compared to a current price of $0.00 — trading 100% below its estimated fair value. The current ROA % is -12.85%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For FOXO Technologies (FOXO), the current ROA % is -12.85% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

FOXO Technologies Business Description

Address 477 South Rosemary Avenue, Suite 224, West Palm Beach, FL, USA, 33401
FOXO Technologies Inc is a healthcare services and technology company. It currently operates four synergistic divisions: (i) a rural hospital division; (ii) a mental and behavioral health division; (iii) an information, data and biospecimen sourcing division; and (iv) an epigenetics diagnostics and interpretation division. The Company manages and classifies its business into three reportable business segments: (i) Healthcare, (ii) Life Science Services and (iii) Labs. Myrtle, RCHI and SCCH operate under the Healthcare segment and Vector operates under the Life Science Services segment. The company generates majority of its revenue from Healthcare segment. It includes RCHI's hospital, BSF, has 25 inpatient beds, and a 24/7 emergency department and provides ancillary services.